184 related articles for article (PubMed ID: 23888049)
1. CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.
Grass GD; Tolliver LB; Bratoeva M; Toole BP
J Biol Chem; 2013 Sep; 288(36):26089-26104. PubMed ID: 23888049
[TBL] [Abstract][Full Text] [Related]
2. MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells.
Meng S; Sørensen EE; Ponniah M; Thorlacius-Ussing J; Crouigneau R; Larsen T; Borre MT; Willumsen N; Flinck M; Pedersen SF
J Cell Sci; 2024 Apr; 137(8):. PubMed ID: 38661040
[TBL] [Abstract][Full Text] [Related]
3. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration.
Murai T; Maruyama Y; Mio K; Nishiyama H; Suga M; Sato C
J Biol Chem; 2011 Jan; 286(3):1999-2007. PubMed ID: 21087933
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: the role of CD147 (EMMPRIN) and ionizing radiation.
Colangelo NW; Azzam EI
Cell Commun Signal; 2020 Feb; 18(1):21. PubMed ID: 32033611
[TBL] [Abstract][Full Text] [Related]
5. NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.
Smith SM; Lyu YL; Cai L
PLoS One; 2014; 9(9):e106966. PubMed ID: 25184276
[TBL] [Abstract][Full Text] [Related]
6. TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.
Wang G; Huang W; Li W; Chen S; Chen W; Zhou Y; Peng P; Gu W
Sci Rep; 2018 Sep; 8(1):14402. PubMed ID: 30258071
[TBL] [Abstract][Full Text] [Related]
7. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.
Baj-Krzyworzeka M; Szatanek R; Weglarczyk K; Baran J; Urbanowicz B; Brański P; Ratajczak MZ; Zembala M
Cancer Immunol Immunother; 2006 Jul; 55(7):808-18. PubMed ID: 16283305
[TBL] [Abstract][Full Text] [Related]
8. Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility.
Chen J; Peng C; Lei L; Zhang J; Zeng W; Chen X
PLoS One; 2017; 12(8):e0183689. PubMed ID: 28832687
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of different anti-CD147/Basigin 2 antibodies as a potential therapeutic anticancer target by molecular modeling and dynamic simulation.
Besli N; Bulut Hİ; Onaran İ; Carmena-Bargueño M; Pérez-Sánchez H
Mol Divers; 2024 Apr; ():. PubMed ID: 38587771
[TBL] [Abstract][Full Text] [Related]
10. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance.
Grass GD; Dai L; Qin Z; Parsons C; Toole BP
Adv Cancer Res; 2014; 123():351-73. PubMed ID: 25081536
[TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Pietanza MC; Waqar SN; Krug LM; Dowlati A; Hann CL; Chiappori A; Owonikoko TK; Woo KM; Cardnell RJ; Fujimoto J; Long L; Diao L; Wang J; Bensman Y; Hurtado B; de Groot P; Sulman EP; Wistuba II; Chen A; Fleisher M; Heymach JV; Kris MG; Rudin CM; Byers LA
J Clin Oncol; 2018 Aug; 36(23):2386-2394. PubMed ID: 29906251
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated hyaluronan limits efficacy of monoclonal antibody therapy.
Singha NC; Nekoroski T; Zhao C; Symons R; Jiang P; Frost GI; Huang Z; Shepard HM
Mol Cancer Ther; 2015 Feb; 14(2):523-32. PubMed ID: 25512619
[TBL] [Abstract][Full Text] [Related]
14. The CD147-HYALURONAN Axis in Cancer.
Toole BP
Anat Rec (Hoboken); 2020 Jun; 303(6):1573-1583. PubMed ID: 31090215
[TBL] [Abstract][Full Text] [Related]
15. Role of MMP-2 and CD147 in kidney fibrosis.
Cheng Z; Zhang X; Zhang Y; Li L; Chen P
Open Life Sci; 2022; 17(1):1182-1190. PubMed ID: 36185410
[TBL] [Abstract][Full Text] [Related]
16. Protein oxidation of fucose environments (POFE) reveals fucose-protein interactions.
Xie Y; Chen S; Alvarez MR; Sheng Y; Li Q; Maverakis E; Lebrilla CB
Chem Sci; 2024 Apr; 15(14):5256-5267. PubMed ID: 38577366
[TBL] [Abstract][Full Text] [Related]
17. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models.
Suzuki H; Ohishi T; Kaneko MK; Kato Y
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894446
[TBL] [Abstract][Full Text] [Related]
18. Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis.
Seo YR; Lee J; Ryu HS; Kim EG; Kim SH; Jeong J; Jung H; Jung Y; Kim HB; Jo YH; Kim YD; Jin MS; Lee YY; Kim KM; Yi EC
Sci Rep; 2023 Aug; 13(1):14242. PubMed ID: 37648771
[TBL] [Abstract][Full Text] [Related]
19. "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Front Oncol; 2023; 13():1201497. PubMed ID: 37448521
[TBL] [Abstract][Full Text] [Related]
20. Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
